Meeting
2022 ASCO Annual Meeting
Disparity in initiation of checkpoint inhibitors among metastatic melanoma and lung cancer.
Authors
Meng Li
University of Texas MD Anderson Cancer Center, Houston, TX
Meng Li , Kai-Ping Eric Liao , Alice Chen , Mackenzie Wehner , Ya-Chen Tina Shih
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Health and Regulatory Policy
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1583)
DOI
10.1200/JCO.2022.40.16_suppl.1583
Abstract #
1583
Poster Bd #
175
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Source of funding and enrollment disparity in cancer clinical trials.
First Author: Irbaz Bin Riaz
Poster
2022 ASCO Quality Care Symposium
Racial and gender disparities in metastatic lung and bronchial cancer (LC) across the United States.
First Author: Devashish Desai
Poster
2024 ASCO Quality Care Symposium
Cross-sectional study of assessment of lung cancer (LC) screening awareness in an underserved community in the Bronx, New York.
First Author: Nehemias Antonio Guevara Rodriguez
Poster
2024 ASCO Breakthrough
Racial impact of secondary metastasis in patients with lung cancer: Evidence of US hospitals in 2020.
First Author: Thanathip Suenghataiphorn